Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ae7bc470b590116f17769a5b53f38cc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001129 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
filingDate |
2002-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c505107192e7ffdafe049f3b174ca8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e92aa4ebb477bd841066a0f82202813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9b9473c3f1be05726dc46d6e168d3cd |
publicationDate |
2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1925317-A1 |
titleOfInvention |
Stabilised mRNA tumour vaccins |
abstract |
The present invention relates to a pharmaceutical composition comprising at least one mRNA comprising at least one region coding for at least one antigen from a tumor, in association with an aqueous solvent and preferably a cytokine, for example GM-CSF, and a process for the preparation of the pharmaceutical Composition. The pharmaceutical composition according to the invention is used in particular for the therapy and / or prophylaxis against cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4035659-A1 |
priorityDate |
2001-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |